Cargando…
Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis
AIM: The aim of this review is to assess the efficacy and safety of tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy. BACKGROUND: Tripterygium wilfordii multiglycosides, a Chinese patent medicine, is widely in-depth research in Chi...
Autores principales: | Jin, Yuxia, Zhang, Jiayuan, Wang, Yunxia, Xiao, Xiao, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004791/ https://www.ncbi.nlm.nih.gov/pubmed/32000425 http://dx.doi.org/10.1097/MD.0000000000018970 |
Ejemplares similares
-
Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study
por: Liu, Shanshan, et al.
Publicado: (2015) -
Efficacy and safety of tripterygium wilfordii multiglycosides in idiopathic membranous nephropathy: Protocol for an open-label randomized controlled clinical trial
por: Geng, Chanyu, et al.
Publicado: (2022) -
Proteomics analysis reveals novel insights into the mechanism of hepatotoxicity induced by Tripterygium wilfordii multiglycoside in mice
por: Miao, Yingying, et al.
Publicado: (2022) -
Kushenin combined with entecavir for chronic hepatitis B: A protocol for a systematic review and meta-analysis
por: Wang, Yunxia, et al.
Publicado: (2020) -
Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy
por: Shang, Shun-Lai, et al.
Publicado: (2018)